Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (54K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (41)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Johnson, G.
Right arrow Articles by Wu, T. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, G.
Right arrow Articles by Wu, T. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2001, Vol. 29, No. 1 205-206
© 2001 Oxford University Press

Kabat Database and its applications: future directions

George Johnson* and Tai Te Wu

Departments of Biochemistry, Molecular Biology and Cell Biology, and Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA

The Kabat Database was initially started in 1970 to determine the combining site of antibodies based on the available amino acid sequences. The precise delineation of complementarity determining regions (CDR) of both light and heavy chains provides the first example of how properly aligned sequences can be used to derive structural and functional information of biological macromolecules. This knowledge has subsequently been applied to the construction of artificial antibodies with prescribed specificities, and to many other studies. The Kabat database now includes nucleotide sequences, sequences of T cell receptors for antigens (TCR), major histocompatibility complex (MHC) class I and II molecules, and other proteins of immunological interest. While new sequences are continually added into this database, we have undertaken the task of developing more analytical methods to study the information content of this collection of aligned sequences. New examples of analysis will be illustrated on a yearly basis. The Kabat Database and its applications are freely available at http://immuno.bme.nwu.edu.

* To whom correspondence should be addressed. Tel: +1 847 491 7849; Fax: +1 847 491 4928; Email: johnson{at}immuno.bme.nwu.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Talavera, R. Friemann, S. Gomez-Puerta, C. Martinez-Fleites, G. Garrido, A. Rabasa, A. Lopez-Requena, A. Pupo, R. F. Johansen, O. Sanchez, et al.
Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation
Cancer Res., July 15, 2009; 69(14): 5851 - 5859.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
M. Schlapschy, M. Fogarasi, H. Gruber, O. Gresch, C. Schafer, Y. Aguib, and A. Skerra
Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains
Protein Eng. Des. Sel., March 1, 2009; 22(3): 175 - 188.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. J. Riley, K. P. Engelhardt, J. W. Saldanha, W. Qi, L. S. Cooke, Y. Zhu, S. T. Narayan, K. Shakalya, K. D. Croce, I. G. Georgiev, et al.
Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer
Cancer Res., March 1, 2009; 69(5): 1933 - 1940.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
C. R. Pigott, M. S. King, and D. J. Ellar
Investigating the Properties of Bacillus thuringiensis Cry Proteins with Novel Loop Replacements Created Using Combinatorial Molecular Biology
Appl. Envir. Microbiol., June 1, 2008; 74(11): 3497 - 3511.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. A. Clark, S. Ganesan, S. Papp, and H. W. T. van Vlijmen
Trends in Antibody Sequence Changes during the Somatic Hypermutation Process
J. Immunol., July 1, 2006; 177(1): 333 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
X. Zhu, P. Wentworth Jr., R. A. Kyle, R. A. Lerner, and I. A. Wilson
Cofactor-containing antibodies: Crystal structure of the original yellow antibody.
PNAS, March 7, 2006; 103(10): 3581 - 3585.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Ghosh, A. C. Steere, B. D. Stollar, and B. T. Huber
In Situ Diversification of the Antibody Repertoire in Chronic Lyme Arthritis Synovium
J. Immunol., March 1, 2005; 174(5): 2860 - 2869.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. C.H.J. Michielsen, J. H.C. Diris, C. M. Hackeng, W. K.W.H. Wodzig, and M. P. Van Dieijen-Visser
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum
Clin. Chem., January 1, 2005; 51(1): 222 - 224.
[Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I. Retter, H. H. Althaus, R. Munch, and W. Muller
VBASE2, an integrative V gene database
Nucleic Acids Res., January 1, 2005; 33(suppl_1): D671 - D674.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
M. Schlapschy, H. Gruber, O. Gresch, C. Schafer, C. Renner, M. Pfreundschuh, and A. Skerra
Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach
Protein Eng. Des. Sel., December 1, 2004; 17(12): 847 - 860.
[Abstract] [Full Text] [PDF]

Home page
 J BiochemHome page
X.-B. Wang, B. Zhou, C.-C. Yin, Q. Lin, and H.-L. Huang
A New Approach for Rapidly Reshaping Single-Chain Antibody In Vitro by Combining DNA Shuffling with Ribosome Display
J. Biochem., July 1, 2004; 136(1): 19 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
P. J. Yazaki, M. A. Sherman, J. E. Shively, D. Ikle, L. E. Williams, J. Y.C. Wong, D. Colcher, A. M. Wu, and A. A. Raubitschek
Humanization of the anti-CEA T84.66 antibody based on crystal structure data
Protein Eng. Des. Sel., May 1, 2004; 17(5): 481 - 489.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Krengel, L.-L. Olsson, C. Martinez, A. Talavera, G. Rojas, E. Mier, J. Angstrom, and E. Moreno
Structure and Molecular Interactions of a Unique Antitumor Antibody Specific for N-Glycolyl GM3
J. Biol. Chem., February 13, 2004; 279(7): 5597 - 5603.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
H. Dreja, L. Gros, S. Villard, E. Bachrach, A. Oates, C. Granier, T. Chardes, J.-C. Mani, M. Piechaczyk, and M. Pelegrin
Monoclonal Antibody 667 Recognizes the Variable Region A Motif of the Ecotropic Retrovirus CasBrE Envelope Glycoprotein and Inhibits Env Binding to the Viral Receptor
J. Virol., October 15, 2003; 77(20): 10984 - 10993.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
N. Hugo, M. Weidenhaupt, M. Beukes, B. Xu, J.-C. Janson, T. Vernet, and D. Altschuh
VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates
Protein Eng. Des. Sel., May 1, 2003; 16(5): 381 - 386.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Kanayama, T. Kimoto, K. Todo, Y. Nishikawa, M. Hikida, M. Magari, M. Cascalho, and H. Ohmori
B Cell Selection and Affinity Maturation During an Antibody Response in the Mouse with Limited B Cell Diversity
J. Immunol., December 15, 2002; 169(12): 6865 - 6874.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
U. Gulati, C.-C. Hwang, L. Venkatramani, S. Gulati, S. J. Stray, J. T. Lee, W. G. Laver, A. Bochkarev, A. Zlotnick, and G. M. Air
Antibody Epitopes on the Neuraminidase of a Recent H3N2 Influenza Virus (A/Memphis/31/98)
J. Virol., October 25, 2002; 76(23): 12274 - 12280.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Lebeau, E. Zeindl-Eberhart, E.-C. Muller, J. Muller-Hocker, P. R. Jungblut, B. Emmerich, and U. Lohrs
Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature
Blood, August 13, 2002; 100(5): 1817 - 1827.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. van den Berg, E. Maggio, R. Rust, K. Kooistra, A. Diepstra, and S. Poppema
Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma
Blood, July 30, 2002; 100(4): 1425 - 1429.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Nagata, M. Onda, Y. Numata, K. Santora, R. Beers, R. J. Kreitman, and I. Pastan
Novel Anti-CD30 Recombinant Immunotoxins Containing Disulfide-stabilized Fv Fragments
Clin. Cancer Res., July 1, 2002; 8(7): 2345 - 2355.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.